Early diagnosis of pancreatic cancer with current standard of care (SOC) methods creates a 50% five year survival benefit, Oregon Health Services... (OHSU) has discovered a blood biomarker for likely even early detection of Pancreatic cancer. It may cost as little as $0.29 when added to an annual blood panel. It is being tested in a general human population to confirm its validity. There is also a promising pancreatic preventive and therapeutic vaccine in the works too.

Prostate cancer: I believe Johns Hopkins has a therapeutic vaccine that is injected into the gland 2 or 3 times. It is said to reduce metastasis in those at risk by 30-40%